KMTS Stock: Price, Earnings History and SEC Filings
Kestra Medical Technologies, Ltd. (KMTS) last traded at $29.69, down 3.01% on the latest session and up 4.9% over the past month. In its most recent reported quarter (Jul 2026) earnings per share were $-0.75 against an analyst estimate of $-0.61, a miss of 23.0%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
KMTS earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jul 2026 | Sep 14, 2026 | $-0.75 | $-0.61 | -22.95% |
| Apr 2026 | Jul 14, 2026 | $-0.67 | $-0.59 | -13.56% |
| Jan 2026 | Mar 17, 2026 | $-0.61 | $-0.60 | -1.67% |
| Oct 2025 | Dec 11, 2025 | $-0.62 | $-0.56 | -10.71% |
KMTS beat the analyst EPS estimate in 0 of its last 4 reported quarters. Source: Nasdaq.
How KMTS reacts to earnings
Across its last 8 earnings releases, KMTS moved 6.6% on average the next session, in either direction. It rose after 5 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-09-14 | After close | +4.66% |
| 2026-07-14 | After close | +1.80% |
| 2026-03-17 | After close | -7.38% |
| 2025-12-11 | After close | +5.06% |
| 2025-12-01 | Before open | -8.49% |
| 2025-09-11 | After close | +18.64% |
| 2025-07-15 | After close | -5.77% |
| 2025-04-14 | After close | +1.26% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
KMTS financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2026 | $95M | -$132M | -$117M | -138.4% | $-2.43 |
| 2025 | $60M | -$114M | -$101M | -190.3% | $-5.13 |
| 2024 | $28M | -$94M | -$84M | -338.4% | $-5.07 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for KMTS
- 10-Q · Sep 14, 2026
- 8-K · Sep 14, 2026Results of operations, Financial statements and exhibits
- 8-K · Sep 10, 2026Shareholder vote
- DEF 14A · Jul 28, 2026
- 10-K · Jul 14, 2026
- 8-K · Jul 14, 2026Material agreement, Agreement terminated, Results of operations
- 10-Q · Mar 17, 2026
- 8-K · Mar 17, 2026Results of operations, Financial statements and exhibits
- 10-Q · Dec 11, 2025
- 8-K · Dec 11, 2025Results of operations, Financial statements and exhibits
Insider filing activity
KMTS insiders filed 18 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
KMTS news
- Kestra Medical Technologies to Participate in Upcoming Investor ConferencesOct 30, 2026 · finance.yahoo.com
About Kestra Medical Technologies, Ltd.
Kestra Medical Technologies, Ltd. (KMTS) is a US-listed public company on Nasdaq. The SEC classifies its business as Surgical & Medical Instruments & Apparatus. It is incorporated in Bermuda. Its fiscal year ends in April.